These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 17713546)

  • 1. Aplidin synergizes with cytosine arabinoside: functional relevance of mitochondria in Aplidin-induced cytotoxicity.
    Humeniuk R; Menon LG; Mishra PJ; Saydam G; Longo-Sorbello GS; Elisseyeff Y; Lewis LD; Aracil M; Jimeno J; Bertino JR; Banerjee D
    Leukemia; 2007 Dec; 21(12):2399-405. PubMed ID: 17713546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aplidin, a marine organism-derived compound with potent antimyeloma activity in vitro and in vivo.
    Mitsiades CS; Ocio EM; Pandiella A; Maiso P; Gajate C; Garayoa M; Vilanova D; Montero JC; Mitsiades N; McMullan CJ; Munshi NC; Hideshima T; Chauhan D; Aviles P; Otero G; Faircloth G; Mateos MV; Richardson PG; Mollinedo F; San-Miguel JF; Anderson KC
    Cancer Res; 2008 Jul; 68(13):5216-25. PubMed ID: 18593922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plitidepsin (Aplidin) is a potent inhibitor of diffuse large cell and Burkitt lymphoma and is synergistic with rituximab.
    Barboza NM; Medina DJ; Budak-Alpdogan T; Aracil M; Jimeno JM; Bertino JR; Banerjee D
    Cancer Biol Ther; 2012 Jan; 13(2):114-22. PubMed ID: 22336911
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Enhancement of the in vivo antitumor activity of clofarabine by 1-beta-D-[4-thio-arabinofuranosyl]-cytosine.
    Parker WB; Shaddix SC; Gilbert KS; Shepherd RV; Waud WR
    Cancer Chemother Pharmacol; 2009 Jul; 64(2):253-61. PubMed ID: 19002461
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Complementary antineoplastic activity of the cytosine nucleoside analogues troxacitabine (Troxatyl) and cytarabine in human leukemia cells.
    Bouffard DY; Jolivet J; Leblond L; Hamelin B; Ouellet F; Barbeau S; Richard A; Gourdeau H
    Cancer Chemother Pharmacol; 2003 Dec; 52(6):497-506. PubMed ID: 12955470
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antitumor effects of celecoxib on K562 leukemia cells are mediated by cell-cycle arrest, caspase-3 activation, and downregulation of Cox-2 expression and are synergistic with hydroxyurea or imatinib.
    Zhang GS; Liu DS; Dai CW; Li RJ
    Am J Hematol; 2006 Apr; 81(4):242-55. PubMed ID: 16550520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Aplidin induces JNK-dependent apoptosis in human breast cancer cells via alteration of glutathione homeostasis, Rac1 GTPase activation, and MKP-1 phosphatase downregulation.
    González-Santiago L; Suárez Y; Zarich N; Muñoz-Alonso MJ; Cuadrado A; Martínez T; Goya L; Iradi A; Sáez-Tormo G; Maier JV; Moorthy A; Cato AC; Rojas JM; Muñoz A
    Cell Death Differ; 2006 Nov; 13(11):1968-81. PubMed ID: 16543941
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Aplidin induces the mitochondrial apoptotic pathway via oxidative stress-mediated JNK and p38 activation and protein kinase C delta.
    García-Fernández LF; Losada A; Alcaide V; Alvarez AM; Cuadrado A; González L; Nakayama K; Nakayama KI; Fernández-Sousa JM; Muñoz A; Sánchez-Puelles JM
    Oncogene; 2002 Oct; 21(49):7533-44. PubMed ID: 12386816
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Aplidin reduces growth of anaplastic thyroid cancer xenografts and the expression of several angiogenic genes.
    Straight AM; Oakley K; Moores R; Bauer AJ; Patel A; Tuttle RM; Jimeno J; Francis GL
    Cancer Chemother Pharmacol; 2006 Jan; 57(1):7-14. PubMed ID: 16001179
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Plitidepsin has a cytostatic effect in human undifferentiated (anaplastic) thyroid carcinoma.
    Bravo SB; García-Rendueles ME; Seoane R; Dosil V; Cameselle-Teijeiro J; López-Lázaro L; Zalvide J; Barreiro F; Pombo CM; Alvarez CV
    Clin Cancer Res; 2005 Nov; 11(21):7664-73. PubMed ID: 16278386
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The cytotoxic activity of Aplidin in chronic lymphocytic leukemia (CLL) is mediated by a direct effect on leukemic cells and an indirect effect on monocyte-derived cells.
    Morande PE; Zanetti SR; Borge M; Nannini P; Jancic C; Bezares RF; Bitsmans A; González M; Rodríguez AL; Galmarini CM; Gamberale R; Giordano M
    Invest New Drugs; 2012 Oct; 30(5):1830-40. PubMed ID: 21887502
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biological pathways and in vivo antitumor activity induced by Atiprimod in myeloma.
    Neri P; Tassone P; Shammas M; Yasui H; Schipani E; Batchu RB; Blotta S; Prabhala R; Catley L; Hamasaki M; Hideshima T; Chauhan D; Jacob GS; Picker D; Venuta S; Anderson KC; Munshi NC
    Leukemia; 2007 Dec; 21(12):2519-26. PubMed ID: 17882285
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Triptolide cooperates with chemotherapy to induce apoptosis in acute myeloid leukemia cells.
    Pigneux A; Mahon FX; Uhalde M; Jeanneteau M; Lacombe F; Milpied N; Reiffers J; Belloc F
    Exp Hematol; 2008 Dec; 36(12):1648-59. PubMed ID: 18922616
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Romidepsin and belinostat synergize the antineoplastic effect of bortezomib in mantle cell lymphoma.
    Paoluzzi L; Scotto L; Marchi E; Zain J; Seshan VE; O'Connor OA
    Clin Cancer Res; 2010 Jan; 16(2):554-65. PubMed ID: 20068080
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bryostatin 1 down-regulates mdr1 and potentiates vincristine cytotoxicity in diffuse large cell lymphoma xenografts.
    Al-Katib AM; Smith MR; Kamanda WS; Pettit GR; Hamdan M; Mohamed AN; Chelladurai B; Mohammad RM
    Clin Cancer Res; 1998 May; 4(5):1305-14. PubMed ID: 9607591
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Synergistic antileukemia effect of genistein and chemotherapy in mouse xenograft model and potential mechanism through MAPK signaling.
    Shen J; Tai YC; Zhou J; Stephen Wong CH; Cheang PT; Fred Wong WS; Xie Z; Khan M; Han JH; Chen CS
    Exp Hematol; 2007 Jan; 35(1):75-83. PubMed ID: 17198876
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Initial testing of aplidin by the pediatric pre-clinical testing program.
    Morton CL; Houghton PJ; Gorlick R; Kolb EA; Lock R; Carol H; Keir ST; Reynolds CP; Kang MH; Maris JM; Billups C; Smith MA
    Pediatr Blood Cancer; 2009 Sep; 53(3):509-12. PubMed ID: 19418543
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The cytotoxic effects of bendamustine in combination with cytarabine in mantle cell lymphoma cell lines.
    Visco C; Castegnaro S; Chieregato K; Bernardi M; Albiero E; Zanon C; Madeo D; Rodeghiero F
    Blood Cells Mol Dis; 2012 Jan; 48(1):68-75. PubMed ID: 22036761
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The addition of bryostatin 1 to cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) chemotherapy improves response in a CHOP-resistant human diffuse large cell lymphoma xenograft model.
    Mohammad RM; Wall NR; Dutcher JA; Al-Katib AM
    Clin Cancer Res; 2000 Dec; 6(12):4950-6. PubMed ID: 11156256
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeting Bcl-2 family proteins in adult T-cell leukemia/lymphoma: in vitro and in vivo effects of the novel Bcl-2 family inhibitor ABT-737.
    Ishitsuka K; Kunami N; Katsuya H; Nogami R; Ishikawa C; Yotsumoto F; Tanji H; Mori N; Takeshita M; Miyamoto S; Tamura K
    Cancer Lett; 2012 Apr; 317(2):218-25. PubMed ID: 22138435
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.